<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2023//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_230101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">35822570</PMID><DateCompleted><Year>2022</Year><Month>07</Month><Day>14</Day></DateCompleted><DateRevised><Year>2023</Year><Month>05</Month><Day>20</Day></DateRevised><Article PubModel="Print"><Journal><ISSN IssnType="Electronic">1576-6578</ISSN><JournalIssue CitedMedium="Internet"><Volume>75</Volume><Issue>2</Issue><PubDate><Year>2022</Year><Month>Jul</Month><Day>16</Day></PubDate></JournalIssue><Title>Revista de neurologia</Title><ISOAbbreviation>Rev Neurol</ISOAbbreviation></Journal><ArticleTitle>[Gastrostomy tubes in patients with amyotrophic lateral sclerosis: indications, safety and experience in a tertiary care centre].</ArticleTitle><Pagination><StartPage>41</StartPage><EndPage>44</EndPage><MedlinePgn>41-44</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.33588/rn.7502.2022116</ELocationID><Abstract><AbstractText Label="AIM">The aim of this study is the clinical characterisation of patients diagnosed with amyotrophic lateral sclerosis (ALS), who were indicated for the placement of a gastrostomy tube (G-Tube) in the period 2007-2017 in the Complejo Asistencial Universitario de Salamanca, and to find possible associated prognostic factors.</AbstractText><AbstractText Label="MATERIAL AND METHODS">It is a descriptive study of clinical cases.</AbstractText><AbstractText Label="RESULTS">Between 2007 and 2017, 139 cases of ALS were assessed and a G-Tube was indicated in 29 of them. Of these 29, on two occasions it was not performed, one due to the patient refusing and the other because of clinical deterioration. Of the total number of G-Tubes, 21 were placed by endoscopy, four by interventional radiology and two by surgery. The main indications were: in 10 cases, for severe dysphagia; in eight cases, for weight loss &gt;10%; and in nine cases, for reduced forced vital capacity &lt;50%. Immediate complications (first 24 hours) included: two intraprocedural desaturations, one ostomy infection, one abdominal pain, one paralytic ileus and one respiratory failure resulting in death. Late complications (first month) include pneumonia, intestinal ischaemia, cellulitis and poor control of secretions. The main cause of death was respiratory failure. The median time elapsed between G-Tube placement and death was 7.89 months. An improvement in analytical nutritional parameters was observed, without showing statistical significance, as a prognostic factor.</AbstractText><AbstractText Label="CONCLUSION">G-Tube placement is an effective and safe procedure to ensure enteral nutrition in ALS patients.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>&#xc1;lvarez-&#xc1;lvarez</LastName><ForeName>M</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Hospital Universitaro de Cabue&#xf1;es, Gij&#xf3;n, Espa&#xf1;a.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Rodr&#xed;guez-L&#xf3;pez</LastName><ForeName>P</ForeName><Initials>P</Initials><AffiliationInfo><Affiliation>Hospital Universitario San Agust&#xed;n, Avil&#xe9;s, Espa&#xf1;a.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Velasco-Guardado</LastName><ForeName>A</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Complejo Asistencial Universitario de Salamanca, Salamanca, Espa&#xf1;a.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>L&#xf3;pez-Alburquerque</LastName><ForeName>T</ForeName><Initials>T</Initials><AffiliationInfo><Affiliation>Complejo Asistencial Universitario de Salamanca, Salamanca, Espa&#xf1;a.</Affiliation></AffiliationInfo></Author></AuthorList><Language>spa</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><VernacularTitle>Sondas de gastrostom&#xed;a en pacientes con esclerosis lateral amiotr&#xf3;fica: indicaciones, seguridad y experiencia en un centro de tercer nivel.</VernacularTitle></Article><MedlineJournalInfo><Country>Spain</Country><MedlineTA>Rev Neurol</MedlineTA><NlmUniqueID>7706841</NlmUniqueID><ISSNLinking>0210-0010</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000690" MajorTopicYN="Y">Amyotrophic Lateral Sclerosis</DescriptorName><QualifierName UI="Q000601" MajorTopicYN="N">surgery</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D004750" MajorTopicYN="N">Enteral Nutrition</DescriptorName><QualifierName UI="Q000379" MajorTopicYN="N">methods</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D005774" MajorTopicYN="N">Gastrostomy</DescriptorName><QualifierName UI="Q000009" MajorTopicYN="N">adverse effects</QualifierName><QualifierName UI="Q000379" MajorTopicYN="N">methods</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012131" MajorTopicYN="Y">Respiratory Insufficiency</DescriptorName><QualifierName UI="Q000150" MajorTopicYN="N">complications</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D062606" MajorTopicYN="N">Tertiary Care Centers</DescriptorName></MeshHeading></MeshHeadingList><OtherAbstract Type="Publisher" Language="spa"><AbstractText Label="TITLE">Sondas de gastrostom&#xed;a en pacientes con esclerosis lateral amiotr&#xf3;fica: indicaciones, seguridad y experiencia en un centro de tercer nivel.</AbstractText><AbstractText Label="UNLABELLED">Objetivo. El objetivo es la caracterizaci&#xf3;n cl&#xed;nica de los pacientes diagnosticados de esclerosis lateral amiotr&#xf3;fica (ELA) a los que se les indic&#xf3; la colocaci&#xf3;n de una sonda de gastrostom&#xed;a (SG) en el per&#xed;odo 2007-2017 en el Complejo Asistencial Universitario de Salamanca, y encontrar posibles factores pron&#xf3;sticos asociados. Material y m&#xe9;todos. Es un estudio descriptivo de casos cl&#xed;nicos. Resultados. Entre 2007 y 2017 se evaluaron 139 ELA y se indic&#xf3; SG en 29 casos. De esos 29, en dos ocasiones no se llev&#xf3; a cabo, en una ocasi&#xf3;n por negativa del paciente y en otra por deterioro cl&#xed;nico. Del total de SG, 21 se colocaron por endoscopia; cuatro, por radiolog&#xed;a intervencionista; y dos, por cirug&#xed;a. Las principales indicaciones fueron: en 10 casos, por disfagia grave; en ocho, por p&#xe9;rdida ponderal &gt; 10%; y en nueve, por disminuci&#xf3;n de la capacidad vital forzada menor de 50%. Entre las complicaciones inmediatas (primeras 24 horas) se observaron: dos desaturaciones intraprocedimiento, una infecci&#xf3;n de la ostom&#xed;a, un dolor abdominal, un &#xed;leo paral&#xed;tico y una insuficiencia respiratoria con fallecimiento. Entre las complicaciones tard&#xed;as (primer mes): una neumon&#xed;a, una isquemia intestinal, una celulitis y un mal control de las secreciones. La principal causa de fallecimiento fue la insuficiencia respiratoria. La mediana de tiempo desde la colocaci&#xf3;n de la SG hasta el fallecimiento fue de 7,89 meses. Se constat&#xf3; mejor&#xed;a de los par&#xe1;metros anal&#xed;ticos nutricionales, sin demostrarse significaci&#xf3;n estad&#xed;stica, como factor pron&#xf3;stico. Conclusi&#xf3;n. La colocaci&#xf3;n de una SG es un procedimiento eficaz y seguro para asegurar la nutrici&#xf3;n enteral en los pacientes con ELA.</AbstractText></OtherAbstract><CoiStatement>Conflicto de intereses: Los autores declaran no tener ning&#xfa;n conflicto de inter&#xe9;s.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="entrez"><Year>2022</Year><Month>7</Month><Day>13</Day><Hour>6</Hour><Minute>23</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2022</Year><Month>7</Month><Day>14</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2022</Year><Month>7</Month><Day>15</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">35822570</ArticleId><ArticleId IdType="pmc">PMC10186723</ArticleId><ArticleId IdType="doi">10.33588/rn.7502.2022116</ArticleId><ArticleId IdType="pii">rn2022116</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>L&#xf3;pez-G&#xf3;mez JJ, Ballesteros-Pomar MD, Torres-Torres B, Pintor-de la Maza B, Penacho-L&#xe1;zaro MA, Palacio-Mures JM, et al. Impact of percutaneous endoscopic gastrostomy (PEG) on the evolution of disease in patients with amyotrophic lateral sclerosis (ALS). Nutrients 2021;13:2765.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8401888</ArticleId><ArticleId IdType="pubmed">34444925</ArticleId></ArticleIdList></Reference><Reference><Citation>L&#xf3;pez-G&#xf3;mez JJ, Ballesteros-Pomar MD, Torres-Torres B, Pintor-de la Maza B, Penacho-L&#xe1;zaro MA, Palacio-Mures JM, et al. Impact of percutaneous endoscopic gastrostomy (PEG) on the evolution of disease in patients with amyotrophic lateral sclerosis (ALS) Nutrients. 2021;13:2765.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8401888</ArticleId><ArticleId IdType="pubmed">34444925</ArticleId></ArticleIdList></Reference><Reference><Citation>Carb&#xf3;-Perseguer J, Madej&#xf3;n-Seiz A, Romero-Portales M, Mart&#xed;nez- Hern&#xe1;ndez J, Mora-Pardinad JS, Garc&#xed;a-Samaniego J. La gastrostom&#xed;a endosc&#xf3;pica percut&#xe1;nea en pacientes diagnosticados de esclerosis lateral amiotr&#xf3;fica:mortalidad y complicaciones. Neurologia 2019;34:582-8.</Citation><ArticleIdList><ArticleId IdType="pubmed">29599075</ArticleId></ArticleIdList></Reference><Reference><Citation>Carb&#xf3;-Perseguer J, Madej&#xf3;n-Seiz A, Romero-Portales M, Mart&#xed;nez- Hern&#xe1;ndez J, Mora-Pardinad JS, Garc&#xed;a-Samaniego J. La gastrostom&#xed;a endosc&#xf3;pica percut&#xe1;nea en pacientes diagnosticados de esclerosis lateral amiotr&#xf3;fica:mortalidad y complicaciones. Neurologia. 2019;34:582&#x2013;8.</Citation><ArticleIdList><ArticleId IdType="pubmed">29599075</ArticleId></ArticleIdList></Reference><Reference><Citation>Salvioni CC, Stanich P, Almeida CS, Oliveira AS. Nutritional care in motor neurone disease/amyotrophic lateral sclerosis. Arq Neuropsiquiatr 2014;72:157-63.</Citation><ArticleIdList><ArticleId IdType="pubmed">24604371</ArticleId></ArticleIdList></Reference><Reference><Citation>Salvioni CC, Stanich P, Almeida CS, Oliveira AS. Nutritional care in motor neurone disease/amyotrophic lateral sclerosis. Arq Neuropsiquiatr. 2014;72:157&#x2013;63.</Citation><ArticleIdList><ArticleId IdType="pubmed">24604371</ArticleId></ArticleIdList></Reference><Reference><Citation>Andersen PM, Abrahams S, Borasio GD, de Carvalho M, Chio A, Van Damme P, et al. EFNS guidelines on the clinical management of amyotrophic lateral sclerosis (MALS)&#x2013;Revised report ofan EFNS task force. Eur J Neurol 2012;19:360-75.</Citation><ArticleIdList><ArticleId IdType="pubmed">21914052</ArticleId></ArticleIdList></Reference><Reference><Citation>Andersen PM, Abrahams S, Borasio GD, de Carvalho M, Chio A, Van Damme P, et al. EFNS guidelines on the clinical management of amyotrophic lateral sclerosis (MALS)&#x2013;Revised report ofan EFNS task force. Eur J Neurol. 2012;19:360&#x2013;75.</Citation><ArticleIdList><ArticleId IdType="pubmed">21914052</ArticleId></ArticleIdList></Reference><Reference><Citation>Onders R, Katirji B, Schilz R, Ponsky J, Elmo M, Kaplan C. Nutrition and respiration combining gastrostomy with diaphragm pacing for improved survival. 21st International Symposium on ALS/MSD. Amyotroph Lateral Scler 2010;11 (Suppl 1):S136.</Citation></Reference><Reference><Citation>Onders R, Katirji B, Schilz R, Ponsky J, Elmo M, Kaplan C. Nutrition and respiration combining gastrostomy with diaphragm pacing for improved survival. 21st International Symposium on ALS/MSD. Amyotroph Lateral Scler. 2010;11(Suppl 1):S136.</Citation></Reference><Reference><Citation>Prior-S&#xe1;nchez I, Herrera-Mart&#xed;nez AD, Tenorio Jim&#xe9;nez C, Molina Puerta MJ, Cala&#xf1;as Continente A, Manzano Garc&#xed;a G, et al. Gastrostom&#xed;a endosc&#xf3;pica percut&#xe1;nea en esclerosis lateral amiotr&#xf3;fica;experiencia en un hospital de tercer nivel. Nutr Hosp 2014;1:1289-94.</Citation><ArticleIdList><ArticleId IdType="pubmed">25433110</ArticleId></ArticleIdList></Reference><Reference><Citation>Prior-S&#xe1;nchez I, Herrera-Mart&#xed;nez AD, Tenorio Jim&#xe9;nez C, Molina Puerta MJ, Cala&#xf1;as Continente A, Manzano Garc&#xed;a G, et al. Gastrostom&#xed;a endosc&#xf3;pica percut&#xe1;nea en esclerosis lateral amiotr&#xf3;fica;experiencia en un hospital de tercer nivel. Nutr Hosp. 2014;1:1289&#x2013;94.</Citation><ArticleIdList><ArticleId IdType="pubmed">25433110</ArticleId></ArticleIdList></Reference><Reference><Citation>Chio A, Galletti R, Finocchiaro C, Righi D, Ruffino MA, Calvo A, et al. Percutaneous radiological gastrostomy:a safe and effective method of nutritional tube placement in advanced ALS. J Neurol Neusurg Psychiatry 2004;75:645-7.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC1739007</ArticleId><ArticleId IdType="pubmed">15026518</ArticleId></ArticleIdList></Reference><Reference><Citation>Chio A, Galletti R, Finocchiaro C, Righi D, Ruffino MA, Calvo A, et al. Percutaneous radiological gastrostomy:a safe and effective method of nutritional tube placement in advanced ALS. J Neurol Neusurg Psychiatry. 2004;75:645&#x2013;7.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC1739007</ArticleId><ArticleId IdType="pubmed">15026518</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>